文献速递神经肿瘤神经重症

高渗盐水与甘露醇在开颅术中脑松弛效果的比较:系统综述与更新Meta分析

Hypertonic Saline Solution Versus Mannitol for Brain Relaxation During Craniotomies: A Systematic Review and Updated Meta-Analysis.
PubMed 文献 · Neurosurgery · 2024-03-29

本更新Meta分析纳入16项随机对照试验共1031例患者,比较高渗盐水(HTS)与甘露醇(MAN)在开颅术中脑松弛的效果。HTS组脑松弛率80% vs MAN组71%(OR 1.68,95%CI 1.22-2.33,P=.001,I²=0%),需追加渗透性药物剂量患者比例14% vs 28%(OR 0.43,95%CI 0.27-0.69,P=.0003,I²=0%),液体入量和尿量均更低;住院时间和局灶性神经功能缺损无显著差异。

要点

  • HTS组脑松弛率80% vs MAN组71%(OR 1.68,95%CI 1.22-2.33,P=.001),优于MAN。
  • HTS组需追加渗透性药物剂量比例14% vs MAN组28%(OR 0.43,95%CI 0.27-0.69,P=.0003)。
  • HTS组液体入量和尿量均低于MAN组,住院时间及局灶性神经功能缺损无显著差异。

核心结论

  • 本更新Meta分析结果一致提示,在开颅术患者中,HTS较MAN与更多获益结局相关。

研究设计与样本

  • 系统检索MEDLINE、Embase和Cochrane数据库至2023年8月2日,纳入16项随机对照试验共1031例患者,其中631例(61%)因幕上肿瘤切除接受手术。
  • 采用Mantel-Haenszel法及95%CI分析数据,使用I²统计量评估异质性,并进行Meta回归分析评估脑松弛评分与肿瘤体积的可能关联,使用R 4.2.3版进行统计分析。

主要发现

  • 与MAN相比,HTS组脑松弛率80% vs 71%(OR 1.68,95%CI 1.22-2.33,P=.001,I²=0%)。
  • 幕上脑肿瘤患者亚组分析中,HTS组脑松弛率78% vs 65%(OR 2.02,95%CI 1.36-2.99,P=.0005,I²=0%)。
  • HTS组需追加第二剂渗透性药物的患者比例14% vs 28%(OR 0.43,95%CI 0.27-0.69,P=.0003,I²=0%)。
  • HTS组液体入量平均差-475.9341 mL(95%CI -818.8952至-132.9730,P=.007,I²=88%),尿量平均差-462.0941 mL(95%CI -585.3020至-338.8862,P<.001,I²=96%)。
  • 住院时间和局灶性神经功能缺损在两组间未达统计学显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The preferred osmotic agent used for brain relaxation during craniotomies remains unclear, either mannitol (MAN) or hypertonic saline (HTS). Hence, we sought to compare these solutions in this population. METHODS: MEDLINE, Embase, and Cochrane databases were systematically searched until August 02, 2023. Data were examined using the Mantel-Haenszel method and 95% CIs. Heterogeneity was assessed using I2 statistics. Meta-regression analysis was conducted to evaluate a possible link between Brain Relaxation Score and tumor volume. R, version 4.2.3, was used for statistical analysis. RESULTS: A total of 16 randomized controlled trials and 1031 patients were included, of whom 631 (61%) underwent surgery for supratentorial tumor resection. Compared with MAN, HTS achieved better rates of brain relaxation (80% vs 71%; odds ratio [OR] 1.68; 95% CI 1.22-2.33; P = .001; I2 = 0%), which was also demonstrated in the subgroup analysis of patients with supratentorial brain tumor (78% vs 65%; OR 2.02; 95% CI 1.36-2.99; P = .0005; I2 = 0%); a minor number of patients requiring a second dose of osmotic agent (14% vs 28%; OR 0.43; 95% CI 0.27-0.69; P = .0003; I2 = 0%); a lower fluid intake (mean difference -475.9341 mL; 95% CI -818.8952 to -132.9730; P = .007; I2 = 88%); and lower urine output (mean difference -462.0941 mL; 95% CI -585.3020 to -338.8862; P = <.001; I2 = 96%). Hospital length of stay and focal neurological deficits did not reach a statistically significant difference between groups. CONCLUSION: In this updated meta-analysis, consistent results suggest that HTS is associated with more beneficial outcomes than MAN in patients undergoing craniotomy.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Menegaz de Almeida A, Viana P, Marinheiro G, et al. Hypertonic Saline Solution Versus Mannitol for Brain Relaxation During Craniotomies: A Systematic Review and Updated Meta-Analysis. Neurosurgery. 2024. PMID: 38551382. doi:10.1227/neu.0000000000002929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。